• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    CNO Financial Group Announces Increase to Securities Repurchase Authorization, Increase to Quarterly Dividend and Results of Annual Shareholder Meeting

    5/7/21 4:15:00 PM ET
    $CNO
    Accident &Health Insurance
    Finance
    Get the next $CNO alert in real time by email

    CARMEL, Ind., May 7, 2021 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE:CNO) announced today that its Board of Directors has approved an additional $500 million to repurchase the company's outstanding common stock. At March 31, 2021, CNO had remaining repurchase capacity under its share repurchase program of approximately $169 million. The repurchase program is intended to be implemented through purchases made from time to time in the open market, through private transactions or by a tender offer, in accordance with Securities and Exchange Commission requirements. The amount and timing of the repurchases (if any) will be based on business and market conditions and other factors.

    (PRNewsfoto/CNO Financial Group)

    The company also announced today that its Board of Directors has approved a $0.01 per share increase in its quarterly dividend, its ninth consecutive annual increase. The Board declared a quarterly cash dividend of $0.13 per share on the company's common shares. The dividend will be payable June 24, 2021, to shareholders of record at the close of business on June 10, 2021.

    In addition, CNO announced that at the company's annual meeting earlier today, its shareholders:

    • Elected 10 directors (Gary C. Bhojwani, Ellyn L. Brown, Stephen N. David, David. B. Foss, Robert C. Greving, Mary R. Nina Henderson, Daniel R. Maurer, Chetlur S. Ragavan, Steven E. Shebik, and Frederick J. Sievert) to serve terms expiring at next year's annual meeting.
    • Approved, by non-binding advisory vote, the executive compensation of the company's named executive officers as disclosed in the proxy statement for the annual meeting.
    • Approved the adoption of the company's Amended and Restated Section 382 Shareholder Rights Plan.
    • Ratified the appointment of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for 2021.

    About CNO Financial Group

    CNO Financial Group, Inc. (NYSE:CNO) secures the future of middle-income America. CNO provides life and health insurance, annuities, financial services, and workforce benefits solutions through our family of brands, including Bankers Life, Colonial Penn and Washington National. Our customers work hard to save for the future, and we help protect their health, income and retirement needs with 3.2 million policies and $35 billion in total assets. Our 3,400 associates, 5,000 exclusive agents and 4,000 independent partner agents guide individuals, families and businesses through a lifetime of financial decisions. For more information, visit CNOinc.com.

    Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cno-financial-group-announces-increase-to-securities-repurchase-authorization-increase-to-quarterly-dividend-and-results-of-annual-shareholder-meeting-301286849.html

    SOURCE CNO Financial Group, Inc.

    Get the next $CNO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CNO

    DatePrice TargetRatingAnalyst
    1/23/2025$38.00Market Perform
    BMO Capital Markets
    4/16/2024$29.00Neutral → Overweight
    Piper Sandler
    1/4/2024$24.00 → $26.00In-line → Underperform
    Evercore ISI
    6/29/2023Mkt Perform
    Raymond James
    9/13/2022$25.00Outperform
    RBC Capital Mkts
    1/26/2022$25.00Hold
    Jefferies
    1/7/2022$27.00 → $28.00Equal-Weight
    Morgan Stanley
    1/5/2022$29.00 → $27.00Overweight → Neutral
    Piper Sandler
    More analyst ratings